Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.11 USD
−145.42 M USD
877.99 M USD
1.51 B
About INNOVENT BIOLOGICS INC
Sector
CEO
De Chao Yu
Headquarters
Suzhou
Website
Founded
2011
FIGI
BBG00PDF9N51
Innovent Biologics, Inc. is a biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases. It operates through the following geographical segments: The People's Republic of China (PRC), the United States of America (USA), and Indonesia. The company was founded by De Chao Yu, Kevin Chen, and Scott M. Wheelwright on April 28, 2011 and is headquartered in Suzhou, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IVBXF is 4.85 USD — it has decreased by −4.62% in the past 24 hours. Watch Innovent Biologics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Innovent Biologics Inc. stocks are traded under the ticker IVBXF.
IVBXF stock has risen by 1.04% compared to the previous week, the month change is a −17.80% fall, over the last year Innovent Biologics Inc. has showed a −11.82% decrease.
We've gathered analysts' opinions on Innovent Biologics Inc. future price: according to them, IVBXF price has a max estimate of 8.86 USD and a min estimate of 4.72 USD. Watch IVBXF chart and read a more detailed Innovent Biologics Inc. stock forecast: see what analysts think of Innovent Biologics Inc. and suggest that you do with its stocks.
IVBXF reached its all-time high on Jan 20, 2021 with the price of 13.50 USD, and its all-time low was 2.29 USD and was reached on May 13, 2022. View more price dynamics on IVBXF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
IVBXF stock is 4.85% volatile and has beta coefficient of 1.08. Track Innovent Biologics Inc. stock price on the chart and check out the list of the most volatile stocks — is Innovent Biologics Inc. there?
Today Innovent Biologics Inc. has the market capitalization of 8.10 B, it has increased by 3.52% over the last week.
Yes, you can track Innovent Biologics Inc. financials in yearly and quarterly reports right on TradingView.
Innovent Biologics Inc. is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
IVBXF earnings for the last half-year are −0.03 USD per share, whereas the estimation was −0.03 USD, resulting in a 4.00% surprise. The estimated earnings for the next half-year are −0.03 USD per share. See more details about Innovent Biologics Inc. earnings.
Innovent Biologics Inc. revenue for the last half-year amounts to 543.68 M USD, despite the estimated figure of 521.16 M USD. In the next half-year revenue is expected to reach 668.11 M USD.
IVBXF net income for the last half-year is −54.47 M USD, while the previous report showed −122.93 M USD of net income which accounts for 55.69% change. Track more Innovent Biologics Inc. financial stats to get the full picture.
No, IVBXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 23, 2024, the company has 4.87 K employees. See our rating of the largest employees — is Innovent Biologics Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Innovent Biologics Inc. EBITDA is −68.48 M USD, and current EBITDA margin is −10.05%. See more stats in Innovent Biologics Inc. financial statements.
Like other stocks, IVBXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Innovent Biologics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Innovent Biologics Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Innovent Biologics Inc. stock shows the sell signal. See more of Innovent Biologics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.